MMEDF News and Press, Mind Medicine From 02/18/21

MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine Company Canada NewsWire Acquisition will help build a full stack digital mental health platform for psychedelic medicines; Ex-Pfizer Digital Medicine Executive Dr. Daniel R. Ka...

Palm Beach, FL – February 17, 2021 – Psychedelics are making their way out of the counterculture and back into the mainstream, with research and media interest in the mind-altering substances growing substantially. Some have even called psychedelics “psychiatry’s...

MindMed's LSD Neutralizer Study Begins PR Newswire Potential Emergency Off-Switch for Psychedelic Assisted Therapies BASEL, Switzerland , Feb. 17, 2021 /PRNewswire/ -- MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine bio...

There has been a boom in magic mushroom interest following Oregon's legalization of psilocybin last year. The few stocks researching the medical uses of psilocybin such as Mind Medicine have seen their share prices rise ~10X over the past six months. Mind Medicine's core research ...

MindMed (OTCQB: MMEDF) (NEO: MMED) (DE: MMQ) , a leading psychedelic medicine biotech company announced a new partnership with Swiss startup MindShift Compounds AG to develop and patent next-gen psychedelic compounds with psychedelic or empathogenic properties. ...

MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds AG, Expands Development Pipeline and IP Portfolio with Next-Gen Psychedelic and Empathogenic Compounds Canada NewsWire ZUG, Switzerland , Feb. 11, 2021 /CNW/ -- MindM...

A New Type Of Vice Stock Is Emerging In 2021 But Should You Buy Them? The excitement in the stock market from massive, short squeezes in Reddit stocks like GameStop ( NYSE: GME ) and AMC Entertainment ( NYSE: AMC ) has sparked a frenzy of retail buying. This excitement h...

MindMed Streamlines Leadership with Further Emphasis on Integrating Psychedelic Drug Development with Digital Medicines and Therapeutics Canada NewsWire J.R. Rahn to become sole CEO; Perry Dellelce to become Chair; Stephen Hurst retires as executive but remains...

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – January 27, 2021 – The ongoing surge of development and investment into psychedelic medicine and psychedelic-assisted therapy is the direct result of newfound public support and legitima...

Mushroom & Psychedelic Stocks Are Hot In 2021 While many traders are looking for the next batch of green energy penny stocks to buy, others have found potential elsewhere. In fact, something huge happened this month that could make psychedelic and mushroom stocks more mainstream. ...